Dean L. Schorno, EVP & Chief Financial Officer at RIGEL PHARMACEUTICALS INC (RIGL), sold 3,770 shares at $20.92 ($81K) on 2025-02-04, disclosed to the SEC on 2025-02-06.
Open-market sale of $81k RIGL by EVP & Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.92 | 2,036 | $43K | 52.8% |
| 2 | $21.93 | 1,734 | $38K | 47.2% |
| Total | $21.38 avg | 3,770 | $81K | 100% |
| Filing → |
| RIGL | BUY | 2019-05-23 | $206K | — | Filing → |
| GHDX | SELL | 2014-06-13 | $110K | — | Filing → |
| GHDX | SELL | 2014-05-13 | $100K | — | Filing → |